Tumor-Infiltrating Lymphocytes Express Vascular Endothelial Growth Factor in Renal Cell Carcinomas
Tumor-Infiltrating Lymphocytes Express Vascular Endothelial Growth Factor in Renal Cell Carcinomas
复制标题
肾细胞癌中肿瘤浸润淋巴细胞表达血管内皮生长因子
DOI:
10.1159/000027212
复制
发表时间:
2000
影响因子:
2.4
通讯作者:
T. Otto
中科院分区:
文献类型:
--
作者:
G. Lümmen;S. Blass;H. Rübben;J. Suhr;T. Otto
Background: Known influence of the immune system on metastases of renal cell cancer (RCC) has led to the development of several therapeutic approaches for further stimulation of the host immune system by cytokines and the retransfusion of tumor-infiltrating lymphocytes (TIL). Based on observations in human prostate adenocarcinomas and transitional cell carcinomas, we have investigated the presence of TIL in different stages of RCC in correlation to vascular endothelial growth factor (VEGF) expression as a parameter for tumor progression and adverse survival in RCC patients. Methods: Samples from surgically obtained RCC (n = 28) and benign renal parenchyma (n =10) were snap-frozen and processed by double-immunofluorescence staining with CD4/CD8 and VEGF antibodies. Results: In 20 of 28 RCCs a coexpression of TIL-specific markers CD4 and/or CD8 and VEGF was demonstrated. Control tissues were VEGF-negative and showed only negligible infiltration by CD4- or CD8-positive lymphocytes. Conclusion: The results indicate that at least 71% of TIL produce VEGF and may promote tumor progression rather than represent an abortive antitumor response of the host immune system.
登录
查看更多内容
影响因子:
6.6
作者:
Figlin, RA;Pierce, WC;Belldegrun, A
通讯作者:
Belldegrun, A
影响因子:
4.4
作者:
G. Peoples;P. Goedegebuure;J. Andrews;D. Schoof;T. Eberlein
通讯作者:
G. Peoples;P. Goedegebuure;J. Andrews;D. Schoof;T. Eberlein
DOI:
10.1073/pnas.91.8.2890
发表时间:
1994-04-12
影响因子:
11.1
作者:
BLOTNICK, S;PEOPLES, GE;KLAGSBRUN, M
通讯作者:
KLAGSBRUN, M
DOI:
10.1073/pnas.92.14.6547
发表时间:
1995
影响因子:
11.1
作者:
Peoples,GE;Blotnick,S;Takahashi,K;Freeman,MR;Klagsbrun,M;Eberlein,TJ
通讯作者:
Eberlein,TJ